Aromatase Inhibitors: When and How to Use Them

What an aromatase inhibitor actually does

Aromatase is the enzyme that converts testosterone (and certain aromatizing anabolic steroids like Dianabol and Anadrol) into estradiol — the main estrogenic hormone. Under exogenous gear at higher doses, aromatization produces estradiol levels well above physiological values. Past a threshold, the estrogenic side effects show up: gyno, water retention, hypertension, mood instability.

An AI blocks that enzyme and brings estradiol production back down. The consensus target for men on cycle is 20 to 40 pg/mL — not more, not less ^{[1] [2]}. That is the range where the physiological benefits of estradiol (libido, joint lubrication, HDL, mood, bone density) stay intact while you avoid the bad effects of an excess.

When to bring in an AI: bloods first

The modern approach, more cautious than what you saw in the 2010s, is to not start an AI prophylactically ^{[5] [6]}. Individual sensitivity to aromatization varies massively; two users on the same cycle can run very different estradiols. Setting the dose blind is flying without instruments.

The recommended protocol

1. Baseline estradiol before the cycle, as part of the baseline blood panel.
2. No AI at the start of the cycle.
3. Mid-cycle bloods (estradiol + clinical signs) at week 4 to 6.
4. If estradiol > 50–60 pg/mL AND estrogenic signs: bring in an AI at a low dose (anastrozole 0.25 mg EOD, exemestane 12.5 mg EOD).
5. Re-check estradiol 2 to 3 weeks later; titrate up or down.

Estrogenic signs to know

• Nipple sensitivity or itching (early sign of gyno).
• Rapid water retention, puffy face, unusual weight gain (see water retention on cycle).
• BP creeping up with no other obvious cause.
• Marked mood swings or heightened emotionality.

Dosing an AI by measured estradiol

The ranges below are indicative and reflect community practice; individual sensitivity can force very different doses ^[3]. It is bloods that validate the dose, not feel.

Anastrozole: consensus ranges

• Low dose: 0.25 mg EOD (every other day).
• Intermediate: 0.5 mg EOD.
• Higher (aggressive cycles or users very sensitive to aromatization): 0.5 to 1 mg EOD, with a fast recheck on bloods.

Exemestane: consensus ranges

• Low dose: 12.5 mg EOD.
• Standard: 12.5–25 mg EOD.
• Higher (rare in performance use): 25 mg daily.

Arimidex vs Aromasin: how to choose

Both molecules hit the same goal (reduce estradiol) through two different mechanisms. That accounts for the practical nuances below.

In practice: anastrozole stays the most used, the most available, the most documented ^[7]. Aromasin is often preferred on a cut (mild androgenic contribution, better HDL profile) and by users who notice an E2 rebound when they stop Adex. Both work — the choice is not decisive.

The estradiol crash: the most underestimated risk

The E2 crash is the direct consequence of an over-dosed AI. Estradiol slides under the useful threshold (< 15–20 pg/mL) and produces its own set of side effects — often misattributed to the cycle itself ^[4].

• Libido collapse, erection problems despite high testosterone.
• Diffuse joint pain (knees, elbows, wrists) — estrogen contributes to joint lubrication.
• HDL tanked, lipid profile severely degraded.
• Low mood, anhedonia, irritability, sometimes frank depression.
• Persistent fatigue despite decent sleep.
• Abnormal thirst, dry skin.

Getting out of a crash

Immediate stop of the AI. Anastrozole being reversible, estradiol climbs back over days to a couple of weeks. Exemestane being irreversible, you wait for new enzyme synthesis (1 to 2 weeks typically). Recheck E2 after that window before any AI re-introduction at a lower dose.

Special cases: progestogenic compounds and HCG

Progestogenic compounds

Nandrolone (deca) and trenbolone (tren) carry progestin activity. An AI alone may not be enough to prevent gyno or erectile dysfunction on deca/tren. Controlling prolactin and the possible use of a prolactin inhibitor (cabergoline) round out the management. Details in the hormonal markers on cycle guide.

HCG and estradiol

HCG, by stimulating testicular Leydig cells, also increases endogenous testosterone production and therefore aromatization. A protocol running HCG alongside a cycle (to preserve testicular volume) has to account for this: estradiol can run higher than expected, and the AI gets adjusted accordingly.

Frequently asked questions